News: COX-2-targeted PET imaging

New Views of Inflammation, Cancer

Friday, October 21st, 2011

The enzyme COX-2 – normally expressed at low levels – increases at sites of inflammation and in pre-malignant and malignant tumors, making it an attractive target for molecular imaging to diagnose and treat cancer. Jashim Uddin, Ph.D., Lawrence Marnett, Ph.D., and colleagues are developing novel imaging agents that selectively bind to COX-2. In work featured […]